Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection

NCT04367740 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT04367740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
April 28, 2020
Completion date
February 28, 2022
Enrollment
6,313 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic condition, communicable disease, coronaviridae infections, coronavirus infections, infection viral, rna virus infections, severe acute respiratory syndrome coronavirus 2, virus diseases